Michael Richman - 30 Jan 2026 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
President & CEO, Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
Issuer symbol
NXTC
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 16:07:18 UTC
Previous filing
03 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Richman Michael President & CEO, Director C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE /s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman 03 Feb 2026 0001366265

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +38,190 $0.000000 38,190 30 Jan 2026 Common Stock 38,190 $10.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.